Alkylated Porphyrins Have Broad Antiviral Activity against Hepadnaviruses, Flaviviruses, Filoviruses, and Arenaviruses
- 1 February 2011
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 55 (2), 478-486
- https://doi.org/10.1128/aac.00989-10
Abstract
We screened ∼2,200 compounds known to be safe in people for the ability to reduce the amount of virion-associated hepatitis B virus (HBV) DNA in the culture medium of producer cells. These efforts led to the discovery of an alkylated porphyrin, chlorophyllide, as the compound that achieved the greatest reduction in signal. Here we report that chlorophyllide directly and quantitatively disrupted HBV virions at micromolar concentrations, resulting in the loss of all detectable virion DNA, without detectably affecting cell viability or intracellular viral gene products. Chemophores of chlorophyllide were also tested. Chlorin e6, a metal-free chlorophyllide-like molecule, showed the strongest antiviral activity against HBV as well as profound antiviral effects on other enveloped viruses, such as hepatitis C virus (HCV), human immunodeficiency virus (HIV), dengue virus (DENV), Marburg virus (MARV), Tacaribe virus (TCRV), and Junin viruses (JUNV). Remarkably, chlorin e6 inactivated DENV at subnanomolar-level concentrations. However, the compound had no antiviral effect against encephalomyocarditis virus and adenovirus, suggesting that chlorin e6 may be less active or inactive against nonenveloped viruses. Although other porphyrin derivatives have been previously reported to possess antiviral activity, this is the first analysis of the biochemical impact of chlorophyllide and chlorin e6 against HBV and of the dramatic anti-infectivity impact upon DENV. The possible application of this family of compounds as antiviral agents, as microbicides and systemic virus neutralizing agents, is discussed.Keywords
This publication has 33 references indexed in Scilit:
- A broad-spectrum antiviral targeting entry of enveloped virusesProceedings of the National Academy of Sciences of the United States of America, 2010
- Production and Function of the Cytoplasmic Deproteinized Relaxed Circular DNA of HepadnavirusesJournal of Virology, 2010
- A Novel Class of meso -Tetrakis-Porphyrin Derivatives Exhibits Potent Activities against Hepatitis C Virus Genotype 1b Replicons In VitroAntimicrobial Agents and Chemotherapy, 2010
- Inhibition of Hepadnavirus Reverse Transcriptase-ε RNA Interaction by Porphyrin CompoundsJournal of Virology, 2008
- A virocidal amphipathic α-helical peptide that inhibits hepatitis C virus infection in vitroProceedings of the National Academy of Sciences of the United States of America, 2008
- Molecular Virology of Hepatitis B Virus for CliniciansClinics in Liver Disease, 2007
- Characterization of the Intracellular Deproteinized Relaxed Circular DNA of Hepatitis B Virus: an Intermediate of Covalently Closed Circular DNA FormationJournal of Virology, 2007
- Cryo-electron microscopy of hepatitis B virions reveals variability in envelope capsid interactionsThe EMBO Journal, 2007
- Critical Design Features of Phenyl Carboxylate-Containing Polymer MicrobicidesAntimicrobial Agents and Chemotherapy, 2006
- Hepatitis B Virus Particle Formation in the Absence of Pregenomic RNA and Reverse TranscriptaseJournal of Virology, 2006